Literature DB >> 27326417

Significant correlation of angiotensin converting enzyme and glycoprotein IIIa genes polymorphisms with unexplained recurrent pregnancy loss in north of Iran.

Shokoufeh Fazelnia1, Touraj Farazmandfar2, Seyed Mohammad Bagher Hashemi-Soteh3.   

Abstract

BACKGROUND: Spontaneous abortion is considered as the most complex problem during pregnancy. Thrombophilia is resumed as a cause of recurrent pregnancy loss (RPL). Glycoprotein IIIa (GPIIIa) gene is involved in thrombosis and abortion. Angiotensin converting enzyme (ACE) converts angiotensin I to angiotensin II and is involved in thrombosis. The most common polymorphism in this gene is the insertion/deletion (I/D).
OBJECTIVE: In this study, we analyzed the association between ACE I/D and GPIIIa c.98C >T polymorphisms in women with unexplained RPL from the north of Iran.
MATERIALS AND METHODS: Sample population consisted of 100 women with unexplained RPL and 100 controls. The ACE I/D and GPIIIa c.98C>T polymorphisms were genotyped by TETRA-ARMS PCR. The association between genotypes frequency and RPL were analyzed using χ(2) and exact fisher tests. Associated risk with double genotype combinations was also investigated by binary logistic regression.
RESULTS: There was significant association between ACE DD genotype and RPL (OR=2.04; 95% CI=0.94-4.44; p=0.036). ACE D Allele was also significantly associated with the RPL (OR=1.59; 95% CI=1.05-2.41; p=0.013). No significant association was observed between GPIIIa c.98C>T polymorphism and RPL.
CONCLUSION: ACE I/D polymorphism may probably be a prognostic factor in female family members of women with the history of recurrent abortion.

Entities:  

Keywords:  Angiotensin converting enzyme; Platelet glycoprotein IIIa; Recurrent abortion

Year:  2016        PMID: 27326417      PMCID: PMC4910031     

Source DB:  PubMed          Journal:  Int J Reprod Biomed (Yazd)        ISSN: 2476-3772


Introduction

Recurrent pregnancy loss (RPL) appears a significant clinical problem affecting approximately 2% of women (1). RPL pathophysiology is poorly understood. Pregnancy loss may be caused by different reasons such as genetic factors, immune defect, infection and anatomical problem (2). However, even after more accurate investigations, as many as 50% of all cases remain unexplained (3). Thrombophilia has been presumed as a cause of RPL (4, 5). Many recent studies have examined the mutations incidence and variants in specific thrombophilic genes on women with unexplained pregnancy loss (4-10). Angiotensin converting enzyme (ACE) is a key component in rennin-angiotensin system which converts angiotensin I to angiotensin II, a potent vasopressor. Many studies have been indicated that ACE affects hemostasis through different mechanisms, including platelet aggregation, blood clotting and fibrinolysis (11-14). The human ACE gene contains variable polymorphic regions that can be used in genetic analysis. A well-known polymorphism is the insertion/deletion (I/D) of 287 base paired (bp) fragment in intron 16 which has been extensively investigated (1). Furthermore, it has been found that ACE D allele leads to increased expression in plasminogen activator inhibitor-1 (PAI-1) level, which can increase the angiotensin II production and enhance the thrombotic events risk (15, 16). Past studies have been indicated that thrombophilic defects affect pregnancy-associated thromboembolism such as preeclampsia and abortion (11). Few recent meta-analysis studies have demonstrated the role of ACE I/D polymorphism in increasing RPL risk (17, 18). Glycoprotein IIIa (GPIIIa) is one of thrombophilic genes involved in modulation of vascular thrombosis. The GPIIb/GPIIIa is an integrin complex in platelet aggregation as a fibrinogen receptor (19). The polymorphism c.98C>T in GPIIIa gene causes an amino acid substitution (p.L33P), leads to the creation of two distinct forms of GPIIb/IIIa antigen on platelets (20). This polymorphism has been associated with stroke in young Caucasian women and risk of premature acute coronary syndromes (21). This variation also results in spiral artery thrombosis and poor placental perfusion, which can explain the correlation of this polymorphism with RPL (22, 23). To date, few studies have established on the relationship between thrombophilic genes and RPL in Iranian population (24-26). We, therefore, determined the association between of ACE I/D and GPIIIa c.98C>T polymorphisms in women from the northern of Iran with unexplained RPL.

Materials and methods

Subjects This case-control study was done carried out during the 2013-2014 year’s in Sari, Iran. A total of 100 women with unexplained RPL aged 20-40 yrs and 100 healthy controls aged 27-44 yrs, with at least two live births and no history of abortion, infertility or endometriosis were comprised. Prior to enrollment, all patients were given an explanation of study nature, and written informed consent was obtained from all individuals. The study protocol was approved by the Clinical Research Ethics Committee in Mazandaran University of Medical Sciences, Sari, Mazandaran. RPL was defined as two or more spontaneous consecutive abortions at 5-20 wks of gestation. Miscarriage history of women with unexplained RPL was examined and cases with anatomic, chromosomal, hormonal, autoimmune or infectious causes were excluded from this study. There was no pregnancy-related problems such as hypertension, diabetes, thyroid abnormalities, etc. in none of cases. Genotyping Genomic DNA was isolated from whole blood by a modified Nucleon BACC II method from whole blood (Tepnel Life Sciences, Manchester, UK). The ACE I/D polymorphism was genotyped using two primers and GPIIIa c.98C>T polymorphism was genotyped using a TETRA-ARMS PCR method (27, 28). The GPIIIa c.98C>T polymorphism primers were designed by Gene Runner software (version 3.05) (Table I). The polymerase chain reaction (PCR) was performed using standard PCR methods with 100-200 ng of DNA template and 5 picomol of each primer and PCR materials (Cinnagen, Tehran, Iran) in thermal cycler (Eppendorf, Hamburg, Germany) as reported previously (29).
Table I

Primers used for genotyping

Primer Sequence (5´3´) Genbank accession No.
ACE I/DNG_011648.1
     ForwardCTGGAGACCACTCCCATCCTTTCT
     ReverseGATGTGGCCATCACATTCGTCAGAT
GPIIIa c.98C>T NG_008332.2
     Forward outerCCTTTCTGTACAACGGTCCT
     Reverse outerCAGATCTTCTGACTCAAGTCCT
     Forward inner (C)CTTACAGGCCCTGCGTCC
     Reverse inner (T)CACAGCGAGGTGAGCACA
PCR conditions for ACE genotyping included one step initial denaturation (94oC for 3 min), 35 cycles (94oC for 45 sec, 60.5oC for 50 sec, and 72oC for 40 sec) and a final extension at 72oC for 5 min. PCR conditions for GPIIIa genotyping also included one step initial denaturation (94oC for 3 min), 35 cycles (94oC for 35 sec, 58oC for 40 sec, and 72oC for 40 sec) and a final extension at 72oC for 5 min. Then, PCR products were electrophoresed in a 1.5% agarose gel (Fermentas, Sankt Leon-Rot, Germany). Statistical analysis Association between genotypes frequency and RPL were analyzed using  2 and Fisher’s exact tests. The risk associated with the double genotype combinations was also investigated by binary logistic regression. Data were analyzed by SPSS software (version 17.0) and p˂0.05 were considered significant.

Results

The ACE I/D Alleles were determined based on Product size-band; 490 bp for the I allele and 190 bp for D allele (Figure 1A). The GPIIIa c.98C>T Alleles were also determined by bands; 395 bp for the C allele (by primers of reverse outer and forward inner), 200 bp for T allele (by primers of forward outer and reverse inner) and 560 bp as control (by primers of outer) (Table I) (Figure 1B). The ACE I/D and GPIIIa c.98C>T genotypes in women with RPL and control group was in accordance with Hardy-Weinberg equilibrium. A few samples from each genotype were confirmed by sequencing. The Genotypic and allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL and control group were shown in tables II and III. The ACE II genotype was observed in 23% of cases, ACE ID genotype in 33% and ACE DD genotype in 44%. The GPIIIa c.98C>T wild-type genotype (TT) was observed in 84% of cases, whereas 16% were heterozygous (TC) and no CC genotype was observed. Our results showed that, there is a significant difference regarding ACEDD genotype between cases and control groups (OR=2.04; 95% CI=0.94-4.44; p=0.036) (Table II).
Figure 1

Electrophoresis pattern of PCR products for detection of polymorphisms.(A)ACE I/D polymorphism. Band of 490 bp and 190 bp are as I allele and D allele respectively. (B)GPIIIa c.98C>T polymorphism. Band of 395 bp and 200 bp are as C allele and T allele respectively. Band of 560 bp is as control

Table II

Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk of I/I versus (I/D + D/D) and (I/I + I/D) versus D/D for RPL was evaluated in dominant and recessive models (n=100)

Case Control OR (95% CI) p-value
ACE I/D
     II23311.00
     DI33401.11 (0.51 - 2.40)0.455
     DD44292.04 (0.94 - 4.44)0.036$
     DI + DD77691.50 (0.76 - 2.97)0.104
     DD44291.00
     DI33400.54 (0.26 - 1.10)0.097
     II23310.48 (0.22 - 1.06)0.071
     DI+II56710.51 (0.28 - 0.93)0.131
GPIIIa c.98C>T
     TT84801.00
     TC16200.76 (0.36 - 1.58)0.469
     CC00--
     TC + CC16200.76 (0.36 - 1.58)0.469

OR: odds ratio

CI: confidence interval

$ significant p-values

Table III

Allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL

Case Control OR (95% CI) p-value
ACE I/D
     I79 (39.5%)102 (51%)1.00
     D121 (60.5%)98 (49%)1.59 (1.05 - 2.41)0.013$
GPIIIa c.98C>T
     T184 (92%)180 (90%)1.00
     C16 (8%)20 (10%)0.78 (0.38 - 1.56)0.491

Data presented as n (%).

$ Significant p-values

OR: odds ratio

CI: confidence interval

Our results also indicated that D Allele is statistically associated with RPL (OR=1.59; 95% CI=1.05-2.41; p=0.013) (Table III). No significant difference was observed between genotypic and allelic frequencies of GPIIIa c.98C>T polymorphism and RPL in case and control groups. In combination analysis, there was no significant association between combination of ACEDD genotype and GPIIIa TT genotype with RPL (Table IV).
Table IV

Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL

Case Control OR (95% CI) p-value
ACE/ GPIIIa
     II/TT20261.00
     II/TC350.78 (0.10 - 4.59)0.389
     DI/TT28301.21 (0.51 - 2.84)0.316
     DI/TC5100.65 (0.15 - 2.52)0.255
     DD/TT36241.95 (0.83 - 4.57)0.067
     DD/TC852.08 (0.50 - 9.29)0.136

OR: odds ratio

CI: confidence interval

Primers used for genotyping Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk of I/I versus (I/D + D/D) and (I/I + I/D) versus D/D for RPL was evaluated in dominant and recessive models (n=100) OR: odds ratio CI: confidence interval $ significant p-values Allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL Data presented as n (%). $ Significant p-values OR: odds ratio CI: confidence interval Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL OR: odds ratio CI: confidence interval Electrophoresis pattern of PCR products for detection of polymorphisms.(A)ACE I/D polymorphism. Band of 490 bp and 190 bp are as I allele and D allele respectively. (B)GPIIIa c.98C>T polymorphism. Band of 395 bp and 200 bp are as C allele and T allele respectively. Band of 560 bp is as control

Discussion

This study was designed to determine the association between certain polymorphisms in ACE and GPIIIa genes and RPL in Mazandaran province, northern Iran. Changes in renin-angiotensin-aldosterone system are involved in pathogenesis of pregnancy complications such as preeclampsia and fetal loss (30, 31). Previous studies elucidated the role of ACE I/D polymorphism in susceptibility to pregnancy loss (32-36). ACE alters hemostasis through some mechanisms, including platelet aggregation, influence on fibrinolysis. Some previous studies have reported an association between the ACE D allele and increased risk of thrombosis (15, 37). Data by Fatini et al demonstrated that the ACE I/D polymorphism may be an important risk factor for RPL (35). Buchholz et al also reported that the ACE DD genotype leads to increased PAI-1 concentration and thus correlated with an increased risk of RPL in Caucasians (14). However, Vettriselvi et al showed no significant association between the frequencies of deletion allele and RPL (1). In this study, we found an association between ACE I/D polymorphism and RPL in our population. This study demonstrated that the DD genotype was more prevalent in RPL cases (44%) than in controls (29%), and D allele by itself might be a risk factor for RPL in this population. Concerning the GPIIIa c.98C>T polymorphism, it seems to increase susceptibility to premature acute coronary syndrome and risk of stroke in young Caucasian women (21). T allele frequency was low in all the past studies which is in contrast with this study (1%-17%), this may be due to small sample size in our study (36, 38, 39). Yenicesu et al reported that heterozygous mutations of GPIIIa c.98C>T (CT) were associated with RPL (38). Goodman et al showed that GPIIIa L33P can identify women at risk for RPL (7). Coulam et al also determined the frequency of GPIIIa L33P in women with RPL history (40). Our results indicated that the GPIIIa c.98 C>T polymorphism was not significantly correlated with RPL. These results are in agreement with the study’s results of, Ozdemir et al, Torabi et al, Pihusch et al, Coulam et al, Goodman et al and Hohlagschwandtner et al (7, 26, 39-42).

Conclusion

The major finding of this study shows that ACE D allele may increase susceptibility to RPL. ACE I/D polymorphism could probably be investigated as one of the prognostic factors in women with RPL history among the family members.
  42 in total

1.  ACE DD genotype: an independent predisposition factor to venous thromboembolism.

Authors:  C Fatini; F Gensini; E Sticchi; B Battaglini; D Prisco; S Fedi; T Brunelli; R Marcucci; A A Conti; G F Gensini; R Abbate
Journal:  Eur J Clin Invest       Date:  2003-08       Impact factor: 4.686

2.  A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Sabri Batun; Abdullah Altintaş
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

3.  Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3, *4, and *6) within an Iranian population (Mazandaran).

Authors:  Seyed Mohammad Bagher Hashemi-Soteh; Fatemeh Sarzare; Fatemeh Merat; Ebrahim Salehifar; Mohammad-Reza Shiran
Journal:  Genet Test Mol Biomarkers       Date:  2011-06-01

4.  Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?

Authors:  Cyle S Goodman; Carolyn B Coulam; Rajasingam S Jeyendran; Vida A Acosta; Roumen Roussev
Journal:  Am J Reprod Immunol       Date:  2006-10       Impact factor: 3.886

5.  Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations.

Authors:  Oztürk Ozdemir; Gonca Imir Yenicesu; Fatma Silan; Binnur Köksal; Sinem Atik; Filiz Ozen; Mert Göl; Ali Cetin
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-02

6.  A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.

Authors:  Gonca Imir Yenicesu; Meral Cetin; Ozturk Ozdemir; Ali Cetin; Filiz Ozen; Cem Yenicesu; Caglar Yildiz; Nadir Kocak
Journal:  Am J Reprod Immunol       Date:  2009-11-10       Impact factor: 3.886

7.  Genetic polymorphisms of the renin-angiotensin system in preterm delivery and premature rupture of membranes.

Authors:  Laura L Valdez-Velazquez; Antonio Quintero-Ramos; Sandra A Perez; Francisco Mendoza-Carrera; Hector Montoya-Fuentes; Fernando Rivas; Norma Olivares; Alfredo Celis; Oscar F Vazquez; Fernando Rivas
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2007-12       Impact factor: 1.636

8.  Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme.

Authors:  S Ueda; H L Elliott; J J Morton; J M Connell
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

9.  Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke.

Authors:  A M Carter; A J Catto; J M Bamford; P J Grant
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-07       Impact factor: 8.311

10.  Homocysteine and stroke: evidence on a causal link from mendelian randomisation.

Authors:  Juan P Casas; Leonelo E Bautista; Liam Smeeth; Pankaj Sharma; Aroon D Hingorani
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

View more
  5 in total

Review 1.  Genetic and epigenetic variations associated with idiopathic recurrent pregnancy loss.

Authors:  Luis Alejandro Arias-Sosa; Iván Darío Acosta; Elkin Lucena-Quevedo; Harold Moreno-Ortiz; Clara Esteban-Pérez; Maribel Forero-Castro
Journal:  J Assist Reprod Genet       Date:  2018-01-09       Impact factor: 3.412

Review 2.  Genetics of recurrent pregnancy loss among Iranian population.

Authors:  Meysam Moghbeli
Journal:  Mol Genet Genomic Med       Date:  2019-07-30       Impact factor: 2.183

3.  Genetic Association of Angiotensin-Converting Enzyme (ACE) Gene I/D Polymorphism with Preterm Birth in Korean Women: Case-Control Study and Meta-Analysis.

Authors:  Noo Ri Lee; In Wook Hwang; Hyung Jun Kim; Yun Dan Kang; Jin Wan Park; Han Jun Jin
Journal:  Medicina (Kaunas)       Date:  2019-06-10       Impact factor: 2.430

4.  The Prevalence Of Specific Gene Polymorphisms Related To Thrombophilia In Egyptian Women With Recurrent Pregnancy Loss.

Authors:  Noha Mahmoud Issa; Dalia A Moaty El-Neily; Sally S El Tawab; Lama M El-Attar
Journal:  J Hum Reprod Sci       Date:  2021-03-30

5.  Association of Angiotensin I Converting Enzyme Insertion/287 bp Deletion Polymorphisms and Proliferative Prostatic Diseases among Lebanese Men.

Authors:  Asmahan A El Ezzi; Jordan M Clawson; Mohammed A El-Saidi; Wissam R Zaidan; Abigail Kovash; Jeremy Orellana; AnnaKarina Thornock; Ruhul H Kuddus
Journal:  Prostate Cancer       Date:  2020-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.